Sanofi Share Buyback from L’Oreal could be “accretive,” CEO says

27.01.2014 - Buying back L'Oreal's 9% stake in Sanofi could be "very accretive" for the French drugmaker, although the idea remains speculative, Sanofi's CEO Chris Viehbacher told the news...